跳至主要内容
临床试验/NCT07012772
NCT07012772招募中2 期

COMBO Endoscopy Oropharyngeal Airway in Sedated Endoscopic Retrograde Cholangiopancreatography for Patients

Zhejiang University2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年6月12日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
50
试验地点
2
主要终点
The incidence of hypoxia

研究概览

简要总结

Hypoxia represents the prevailing adverse occurrence during the sedation of patients undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP) with propofol. A recent innovation in this domain is the COMBO Endoscopy Oropharyngeal Airway-a multifaceted device that encompasses capnography monitoring, bite block , oxygenation support, and oropharyngeal airway management. This device has been purposefully designed to cater to the unique requirements of endoscopic procedures. The principal objective of this study is to assess the efficacy of the COMBO Endoscopy Oropharyngeal Airway in reducing the incidence of hypoxia in patients undergoing ERCP under sedation.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years;
  • The ASA classification ranges from I to III.
  • Patients have signed the informed consent form.
  • Patients scheduled to undergo sedated ERCP examination;
  • The estimated duration of the procedure does not exceed 45 minutes.

排除标准

  • Patients with coagulation disorders, tendency for oral/nasal bleeding, mucosal injury/occupying lesions, or difficult oropharyngeal airway insertion making airway management unfeasible;
  • Severe cardiac dysfunction (<4 METs);
  • Severe renal insufficiency (requiring preoperative dialysis);
  • Child-Pugh class C;
  • Diagnosed chronic obstructive pulmonary disease (COPD) or other acute/chronic pulmonary diseases requiring long-term/intermittent oxygen therapy;
  • Increased intracranial pressure;
  • Upper respiratory tract infections (oral/nasal/pharyngeal);
  • Fever (core temperature >37.5°C);
  • Confirmed pregnancy or current breastfeeding;
  • Allergy to sedatives (e.g., propofol) or medical adhesives;
  • Emergency procedures;
  • Multiple trauma injuries;
  • Peripheral oxygen saturation (SpO2) levels below 95% while breathing room air preoperatively;
  • BMI <18.5 or >30 kg/m²;
  • Current participation in other clinical trials;
  • Other conditions deemed ineligible by investigators.

结局指标

主要结局

The incidence of hypoxia

时间窗: Patients will be followed for the duration of hospital stay, an expected average about 2 hours

75% ≤ SpO2 \< 90% for \<60 s

次要结局

  • The incidence of sub-clinical respiratory depression(Patients will be followed for the duration of hospital stay, an expected average about 2 hours)
  • The incidence of severe hypoxia(Patients will be followed for the duration of hospital stay, an expected average about 2 hours)

研究者

发起方
Zhejiang University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Diansan Su

Chair of the Department of Anesthesiology

Zhejiang University

研究点 (2)

Loading locations...

相似试验